Pyridine-2-carboxylic acid (3-amino-phenyl)-amide
|
- $378 - $874
- Product name: Pyridine-2-carboxylic acid (3-amino-phenyl)-amide
- CAS: 90209-80-6
- MF: C12H11N3O
- MW: 213.24
- EINECS:
- MDL Number:MFCD02233010
- Synonyms:2-Pyridinecarboxamide, N-(3-aminophenyl)-;Pyridine-2-carboxylic acid (3-amino-phenyl)-amide
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product number2689AF
- Product descriptionPyridine-2-carboxylicacid(3-amino-phenyl)-amide
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0033884
- Product descriptionPYRIDINE-2-CARBOXYLIC ACID (3-AMINO-PHENYL)-AMIDE 95.00%
- Packaging500MG
- Price$762.3
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11021564
- Product descriptionN-(3-Aminophenyl)picolinamide 97%
- Packaging5g
- Price$874
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number008244
- Product descriptionPyridine-2-carboxylic acid (3-amino-phenyl)-amide
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 2689AF | Pyridine-2-carboxylicacid(3-amino-phenyl)-amide | 1g | $560 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0033884 | PYRIDINE-2-CARBOXYLIC ACID (3-AMINO-PHENYL)-AMIDE 95.00% | 500MG | $762.3 | 2021-12-16 | Buy |
| Crysdot | CD11021564 | N-(3-Aminophenyl)picolinamide 97% | 5g | $874 | 2026-05-26 | Buy |
| Matrix Scientific | 008244 | Pyridine-2-carboxylic acid (3-amino-phenyl)-amide | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|




